HPR6 An Overview of New Payment System for Innovative Medical Technologies in Korea

This article provides an overview of new payment schemes for Innovative medical technologies (IMT) to be applied in January 2022 Korea. We wrote paper by extracting important matters from contents determined task force develop scheme on IMT Health Insurance Review and Assessment Service conclusion drawn through full consultation with relevant government agencies stakeholder. The refers that has substantial potential such as technological innovation, patient’s needs among have been recognized safety but still lack evidence effectiveness. is allowed certain period (up 5 years) at specific institution designated minister health notified law. After being announced IMT, it’s temporarily registered preliminary registration. registration not official the can accumulate during after then they request final listing technology assessment identifying If restriction selection (higher significance or no alternatives list) occurred enrollment period, 10% coinsurance non-reimbursement rest code will assigned manage separately existing system. undergo re-evaluation confirm its effectiveness end So far, 3 applications made 3D printing surgery guides, stem cell therapy, genetic testing prognosis prediction. Even case digital therapeutics, if efficacy cannot proven approval Ministry Food Drug Safety, there possibility it reviewed category IMT. Introduction expected improve benefit patients early introduction recovery absence alternative treatment.